Publicaciones en las que colabora con Manuel Desco Menéndez (21)

2008

  1. Differential clinical, structural and P300 parameters in schizophrenia patients resistant to conventional neuroleptics

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 32, Núm. 1, pp. 257-266

  2. Gray matter deficits in bipolar disorder are associated with genetic variability at interleukin-1 beta gene (2q13)

    Genes, Brain and Behavior, Vol. 7, Núm. 7, pp. 796-801

2007

  1. Changes in cortical volume with olanzapine in chronic schizophrenia

    Pharmacopsychiatry, Vol. 40, Núm. 4, pp. 135-139

  2. Dorsolateral prefrontal N-acetyl-aspartate concentration in male patients with chronic schizophrenia and with chronic bipolar disorder

    European Psychiatry, Vol. 22, Núm. 8, pp. 505-512

2005

  1. Cerebral metabolic changes induced by clozapine in schizophrenia and related to clinical improvement

    Psychopharmacology, Vol. 178, Núm. 1, pp. 17-26

  2. Hypofrontality in men with first-episode psychosis

    British Journal of Psychiatry, Vol. 186, Núm. MAR., pp. 203-208

  3. Increase in gray matter and decrease in white matter volumes in the cortex during treatment with atypical neuroleptics in schizophrenia

    Schizophrenia Research, Vol. 80, Núm. 1, pp. 61-71

  4. N-acetyl-aspartate levels in the dorsolateral prefrontal cortex in the early years of schizophrenia are inversely related to disease duration

    Schizophrenia Research, Vol. 73, Núm. 2-3, pp. 209-219

  5. Olanzapine-induced cerebral metabolic changes related to symptom improvement in schizophrenia

    International Clinical Psychopharmacology, Vol. 20, Núm. 1, pp. 13-18

  6. Ventricular enlargement in schizophrenia is associated with a genetic polymorphism at the interleukin-1 receptor antagonist gene

    NeuroImage, Vol. 27, Núm. 4, pp. 1002-1006

2003

  1. Anatomical and functional brain variables associated with clozapine response in treatment-resistant schizophrenia

    Psychiatry Research - Neuroimaging, Vol. 124, Núm. 3, pp. 153-161

  2. Anatomical and functional cerebral variables associated with basal symptoms but not risperidone response in minimally treated schizophrenia

    Psychiatry Research - Neuroimaging, Vol. 124, Núm. 3, pp. 163-175

  3. Cerebral metabolic patterns in chronic and recent-onset schizophrenia

    Psychiatry Research - Neuroimaging, Vol. 122, Núm. 2, pp. 125-135

  4. Cerebral metabolism and risperidone treatment in schizophrenia

    Schizophrenia Research, Vol. 60, Núm. 1, pp. 1-7

  5. Influence of the normalization template on the outcome of statistical parametric mapping of PET scans

    NeuroImage, Vol. 19, Núm. 3, pp. 601-612

2002

  1. Association between relative temporal and prefrontal sulcal cerebrospinal fluid and illness duration in schizophrenia

    Schizophrenia Research, Vol. 58, Núm. 2-3, pp. 305-312

  2. Effect of the normalization template in statistical parametric mapping of PET scans

    Proceedings - International Symposium on Biomedical Imaging

  3. Effect of the normalization template in statistical parametric mapping of PET scans

    2002 IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING, PROCEEDINGS

  4. Multimodal neuroimaging studies and neurodevelopment and neurodegeneration hypotheses of schizophrenia

    Neurotoxicity Research, Vol. 4, Núm. 5-6, pp. 437-451

2001

  1. Multimodality image quantification using Talairach grid

    Proceedings of SPIE - The International Society for Optical Engineering, Vol. 4322, Núm. 3, pp. 1385-1392